Company profile
UK company 11669397, incorporated on 9 November 2018.
Echopoint - Precision Interventions with Optical Sensing
Echopoint Medicals iKorTM platform enables therapy guidance with just one device in one intuitive step within current workflow.
Company number 11669397
Updated 07 Jul 2026 09:49
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
CS01 | Transaction MzUyOTg2ODQ3NWFkaXF6a2N4
Published 01 Jul 2026 14:40
SH01 | Transaction MzUyOTg1NzEwMWFkaXF6a2N4
Published 01 Jul 2026 13:41
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
Echopoint Medical develops cardiovascular medical devices.
Echopoint Medical is developing
Echopoint Medical Ltd (EML) is a medical device company focused on transforming precision diagnosis and treatment of cardiovascular disease. A spin-out from the University College London, we are translating breakthroughs in fibre-optic sensor technology to address key unmet needs of patients with cardiovascular disease, clinicians, and healthcare providers. Echopoint Medical are pioneering a new sensing technology address a key need: to provide concurrent invasive pressure and flow measurements from inside coronary arteries to significantly improve diagnosis and treatment for patients with cardiovascular disease.
1 Jun 2020 to 30 Nov 2020
no public description
1 May 2020 to 31 Jan 2022
Echopoint Medical are a new med-tech start-up who are focused on developing new technology to significantly improve diagnosis and treatment of cardiovascular disease (CHD). Globally, cardiovascular disease is the leading cause of death among women and men (1.8M patients in the UK). Many of these patients have narrowings or blockages of blood vessels in th...
1 Jun 2019 to 31 Aug 2021
This project is focused on the development of a new medical device to improve diagnosis and treatment of Coronary Heart Disease (CHD). CHD remains the leading cause of death worldwide. Patient symptoms occur when a build-up of plaque restricts coronary blood flow. Clinicians' decisions about treatment are often guided by data from medical devices placed i...
1 Jun 2019 to 30 Nov 2022
"Echopoint are a UK-based medical technology SME at the cutting edge of enhanced diagnostics. Their first product will address the urgent need for better assessment of blood flow within heart arteries during stenting procedures for heart attacks, enabling a precise diagnosis of the patient's condition and patient-specific recommendations for treatment. Th...
